Every year, BFMV conducts a national direct-to-physician call coverage survey. This project offers valuable insights that inform our...

BFMV is pleased to present the 2025 edition of our newest resource   for the healthcare industry. We researched publicly reported...

The One Big Beautiful Bill Act was signed into law on July 4, 2025, by President Donald Trump. The bill cuts taxes and reduces government spending, particularly in healthcare programs like Medicaid and Medicare. Its goal is to lower the federal deficit while changing how healthcare is funded and delivered across the U.S. These changes could lead to tighter hospital budgets and greater pressure on physician pay, particularly in lower-income and rural areas. Cuts to Medicaid A

BuckheadFMV conducted our seventh annual direct-to-physician call coverage survey . An affordable source of physician call coverage compensation information, the BFMV survey is unique in that it provides statistics related to the "burden" of off-site/unrestricted call coverage in a variety of specialties, including in-person visits and phone call volumes. The following is a summary of 5 key background and demographic statistics from the 2025 survey.   1. Respondents by Specia

BFMV’s Cost of Physician Staffing Services, 2025 (“CPSS”) includes data sourced from government contracts with 107 physician staffing companies located across the country. These companies supply government healthcare providers, such as VA hospitals or clinics, with the medical personnel necessary to fill temporary physician vacancies. The companies included in the CPSS also provide these services to non-government clients.   When a physician staffing firm becomes a governmen

BuckheadFMV announces the release of the 2025 Cost of Physician Staffing Services Report. The report compiles pricing data included in 107 government contracts for physician staffing services. Download the free executive summary here . Benchmarks include average, median, 25th, 75th, and 90th percentile hourly rates charged by commercial staffing companies for on-site physician staffing services and after-hours physician call coverage. Approximately 87 specialties and allied h

Not only is BFMV’s seventh annual direct-to-physician call coverage survey an affordable source of physician call coverage compensation information, but it is also unique in that it provides statistics related to the "burden" of unrestricted call, including in-person visits and phone call volumes for a variety of specialties. The following is a summary of key burden statistics from the 2025 survey. 1. Median Days of Coverage per Month Data for physicians in cardiothoracic su

BuckheadFMV ("BFMV") is pleased to announce that Lin Hsu, CVA, has joined BFMV's physician compensation valuation practice. Lin provides fair market value opinions for a wide range of physician services and related arrangements involving hospitals, health systems, and other healthcare providers. Lin was first introduced to healthcare valuation during her time as a college intern at BFMV. After earning her bachelor's degree in finance from Georgia State University, she joined

BFMV is pleased to announce the release of our 2025 BFMV Physician Call Coverage Burden and Compensation Survey . Through our direct-to-physician approach, we received responses from over 1,800 physicians across a wide range of specialties, geographies, demographic settings, and employers. The survey includes unique on-call burden and compensation information, much of which is unavailable from other survey resources, including the following: Compensation (hourly and per 24-ho

In our work with health systems, we sometimes consider an FMV range for compensation that can be used as part of a retention strategy for a high-value employed physician. These situations usually involve a “flight-risk” physician whose employment is essential for a critical service line, and whom the employer is typically highly motivated to retain. From time to time , during related negotiations, such a physician requests compensation above the regional market’s 90th percent

The 2025 BFMV Physician Call Coverage Burden and Compensation Survey is in data collection, and findings will be coming soon... You’re invited to take advantage of a $500 early bird discount on access to the survey findings to be released in mid-June. (The regular subscription price is $3,500.) Use 2025EB$500 at checkout in our shop . Offer expires 12:00 NOON EST, June 13, 2025. A 1-Year Subscription to the 2025 BFMV Physician Call Coverage Burden and Compensation Survey Inc

The Department of Justice (DOJ) news page features several noteworthy settlements related to individual physicians involved in alleged medical laboratory kickback schemes. Enforcement action is likely to continue in the medical lab industry, which is upward of $250.9 billion in size and still growing. [1] Physicians who are key to this growth may not realize the extent of their exposure to prosecution in arrangements that seem like win-wins. However, common threads throughou

Hospitals and health systems nationwide are negotiating supplemental payments with their private radiology group affiliates. These payments help ensure the radiologists are paid fair market value compensation for their hospital facility services. In our work helping facilitate discussions between radiology groups and health systems, we've observed a stumbling block: the story told by compensation surveys as to what private groups should be collecting per work RVU does not ref

Work RVUs (wRVUs) are commonly used to measure physician productivity, a ccounting for the technical skills, physical effort, mental effort, judgment, and the amount of time required to perform a given service or procedure. Under many physician compensation plans, a physician is paid a specific dollar amount per wRVU generated. Significant amounts of money may be tied to wRVUs, so it is important that health systems and physicians have confidence that wRVU totals accurately r

Recently, DOJ announced  that pharmaceutical giant Pfizer, on behalf of its subsidiary, Biohaven Pharmaceutical Holding Company Ltd. (“Biohaven”), has agreed to pay nearly $60 million to resolve allegations that Biohaven knowingly caused the submission of false claims to Medicare and other federal health care programs by paying kickbacks to health care providers (“HCPs”) to induce prescriptions of Biohaven’s migraine drug Nurtec ODT before Pfizer acquired the company. The set